V-Raf-1 Murine Leukemia Viral Oncogene Homolog 1 (RAF1) (AA 2322-2423) peptide (GST tag)
-
- Target See all RAF1 products
- RAF1 (V-Raf-1 Murine Leukemia Viral Oncogene Homolog 1 (RAF1))
- Peptide Type
- Recombinant
- Protein Region
- AA 2322-2423
- Origin
- Hepatitis C Virus (HCV)
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This RAF1 peptide is labelled with GST tag.
- Application
- Western Blotting (WB), ELISA
- Characteristics
-
Hepatitis C Virus NS5 Genotype-1 a (2322-2423) recombinant protein
Expression System: E.coli - Purification
- Proprietary chromatographic technique
- Purity
- > 95 % pure
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Buffer
- 50 mM Tris, pH 8.0, with 0 mM EDTA.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- RT/-20 °C
-
- Target
- RAF1 (V-Raf-1 Murine Leukemia Viral Oncogene Homolog 1 (RAF1))
- Synonyms
- CRAF Peptide, NS5 Peptide, Raf-1 Peptide, c-Raf Peptide, c-raf Peptide, craf Peptide, raf1 Peptide, RAF1 Peptide, 6430402F14Rik Peptide, AA990557 Peptide, BB129353 Peptide, Craf1 Peptide, D830050J10Rik Peptide, v-Raf Peptide, raf Peptide, cRaf Peptide, Raf-1 proto-oncogene, serine/threonine kinase Peptide, Raf-1 proto-oncogene, serine/threonine kinase a Peptide, v-raf-leukemia viral oncogene 1 Peptide, Raf-1 proto-oncogene, serine/threonine kinase S homeolog Peptide, RAF1 Peptide, Raf1 Peptide, raf1a Peptide, raf1 Peptide, raf1.S Peptide
- Background
-
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Alternative Names: HCV NS5 protein, Hepatitis C protein, HCV protein, Hep C protein, HCV Recombinant protein - Molecular Weight
- 38.34 kDa
-